Table 1.
Controls | NMPOU | Value | df | p | |
---|---|---|---|---|---|
(n = 29) | (n = 21) | ||||
Female/male | 10/19 | 5/16 | χ2 = 0.66 | 1 | 0.416 |
Age | 26.6 (8.1) | 28.7 (10.4) | t = −0.83 | 48 | 0.411 |
Years of education | 11.5 (1.5) | 11.1 (2.0) | t = 0.67 | 35.6 | 0.507 |
Ethnicity | |||||
White/European | 29 | 17 | |||
Black/African-Europeana | 0 | 2 | |||
Asian | 0 | 0 | |||
Hispanic/Latinoa | 0 | 2 | |||
Verbal IQ | 105.2 (11.3) | 106.4 (11.2) | t = −0.37 | 50 | 0.717 |
BDI sum score | 3.0 (3.3) | 9.8 (7.9) | t = −4.16 | 48 | <0.001 |
BMI | 22.2 (2.6) | 24.1 (3.5) | t = −1.95 | 48 | 0.058 |
Smoking y/n | 18/11 | 15/6 | χ2 = 0.48 | 1 | 0.490 |
Cigarettes/weekb | 45.4 (35.7) | 87.8 (57.7) | t = −2.50 | 22.5 | 0.021 |
Alcohol y/n | 27/2 | 19/2 | χ2 = 0.11 | 1 | 0.735 |
Alcohol gram/weekb | 74.8 (64.9) | 61.0 (64.4) | t = 0.71 | 44 | 0.479 |
Opioid use | |||||
Times per week | – | 3.9 (3.1) | |||
ME mg/week | – | 586.2 (1001) | |||
Years of usec | – | 2.9 (0.5–28.0) | |||
Last opioid used in hoursc | – | 24.0 (1–729.6) | |||
OUD in percentaged | 76 | ||||
Craving (NRS) | – | 3.3 (2.6) | |||
Opioid withdrawal (OOWS) | – | 1.0 (2.1) | |||
Positive urine tests y/n | 0/29 | 10/11 | |||
ME hair concentration pg/mg | 1 (4) | 5084 (7314) | |||
Cannabis use | |||||
Cannabis use y/n | 9/20 | 13/8 | χ2 = 4.71 | 1 | 0.030 |
g/weekb | 0.21 (0.5) | 0.62 (0.7) | U = 25.0 | 0.025 | |
Years of useb | 4.50 (3.1) | 1.87 (1.6) | U = 24.0 | 0.020 | |
Positive urine tests (y/n) | 0/29 | 5/16 |
Significant p-values (p < 0.05) are shown in bold. T-test and Mann–Whitney U test for quantitative data, Chi2 for frequency data.
BDI Beck’s Depression Inventory, BMI Body Mass Index, ME morphine equivalent, NRS numeric rating scale (1–10), OOWS objective opioid withdrawal scale (0–12), OUD Opioid Use Disorder.
aAt least one parent with this ethnically background.
bOnly within users.
cMedian (range) are reported.
dFulfilling DSM 5 criteria of OUD (moderate to severe).